EUVIMEDEUVIMED entdecken
Crossref

SIRT3 Activation by SGLT2 Inhibitor Mitigates Endothelial-To-Mesenchymal Transition in Dahl Salt-Sensitive Rats Induced by High-Salt Diet

Xiu-Heng Wang, Jia-Yang Yang, Zheng-Wen Lei, Xue-Ting Zheng, Hui-Yi Xie, Hong Huang, Hui-Fang Tang, Yue Zhao, Zhi-Sheng Jiang, Heng-Jing Hu iD

American Journal of Hypertension · 01.04.2026 · 39 (4) · 578-585

DOI: 10.1093/ajh/hpaf209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, online erschienen am 28.10.2025. Verfasst von Xiu-Heng Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital,Department of Metabolism and Endocrinology, Hengyang Medical School, University of South China, Hengyang, Hunan, P.R. C…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Sirtuin 3, Sodium Chloride, Dietary, Hypertension. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province of China, National Key Clinical Specialty Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Salt-sensitive hypertension (SSHT) is associated with reduced expression of SIRT3 and promotes endothelial–mesenchymal transition (EndMT). Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as dapagliflozin (DAPA), have been shown to ameliorate high-salt-induced hypertension. We hypothesized that DAPA attenuate SSHT-induced EndMT and reduce myocardial fibrosis by upregulating SIRT3 expression. This study aims to provide new insights into the mechanisms underlying the cardioprotective effects of SGLT2 inhibitors in hypertension.

Methods

Seven-week-old male Dahl salt-sensitive rats were fed either a high-salt diet (8% NaCl; HSD group), a normal-salt diet (0.3% NaCl; NSD group), or an HSD supplemented with DAPA (2 mg/kg/day administered via drinking water). Systolic blood pressure (SBP) was measured, and left atrial tissue was examined for fibrosis and the expression of SIRT3 and EndMT-related markers, including CD31, Snail, FSP1, Twist, VE-cadherin, and α-SMA.

Results

Compared with the NSD group, the HSD group exhibited increased SBP, left atrial end-systolic volume index (LAESVI), incidence and duration of atrial fibrillation (AF), and atrial fibrosis. Expression of α-SMA, Snail, FSP1, and Twist was elevated, while SIRT3, CD31, and VE-cadherin expression were decreased, along with reduced left atrial ejection fraction and left atrial function index. DAPA treatment reversed these changes.

Conclusions

Our findings indicate that a high-salt diet decreases SIRT3 expression, induces EndMT, and promotes myocardial fibrosis in SSHT rats. DAPA mitigates high-salt-induced EndMT and fibrosis-related AF by upregulating SIRT3, suggesting a potential mechanism for the cardioprotective effects of SGLT2 inhibitors in SSHT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsSirtuin 3Sodium Chloride, DietaryHypertensionBenzhydryl CompoundsGlucosidesEpithelial-Mesenchymal TransitionAnimalsRats, Inbred DahlMaleFibrosisDisease Models, AnimalBlood PressureMyocardiumRatsSirtuins

Stichwörter der Autor:innen

Sodium-glucose cotransporter 2 inhibitorsatrial fibrosisblood pressureendothelial mesenchymal transitionsalt-sensitive hypertension

Substanzen

Sodium-Glucose Transporter 2 InhibitorsSirtuin 3Sodium Chloride, DietaryBenzhydryl CompoundsSIRT3 protein, ratGlucosidesSirtuins

Autor:innen und Institutionen

  • The First Affiliated Hospital,Department of Metabolism and Endocrinology, Hengyang Medical School, University of South China, Hengyang, Hunan, P.R. China.
  • The First Affiliated Hospital, Department of Cardiovascular Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan, P.R. China.
  • The First Affiliated Hospital, Department of Thoracic and cardiovascular surgery, Hengyang Medical School, University of South China, Hengyang, Hunan, P.R. China.
  • Department of Cardiovascular Disease and Key Lab for Atherosclerosis of Hunan Province, Hengyang Medical School, University of South China, Hengyang, Hunan, P.R. China.

ORCID-Profile: Heng-Jing Hu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province of China
  • National Key Clinical Specialty Scientific Research Project
  • Scientific Research Fund Project of Hunan Provincial Health Commission
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • Innovation Platform and Talent Program

Zitieren

APA

Wang, X. H., Yang, J. Y., Lei, Z. W., Zheng, X. T., Xie, H. Y., Huang, H., Tang, H. F., Zhao, Y., Jiang, Z. S., & Hu, H. J. (2026). SIRT3 Activation by SGLT2 Inhibitor Mitigates Endothelial-To-Mesenchymal Transition in Dahl Salt-Sensitive Rats Induced by High-Salt Diet. American Journal of Hypertension, 39(4), 578-585. https://doi.org/10.1093/ajh/hpaf209

Vancouver

Wang XH, Yang JY, Lei ZW, Zheng XT, Xie HY, Huang H, et al. SIRT3 Activation by SGLT2 Inhibitor Mitigates Endothelial-To-Mesenchymal Transition in Dahl Salt-Sensitive Rats Induced by High-Salt Diet. American Journal of Hypertension. 2026;39(4):578-585. doi:10.1093/ajh/hpaf209

BibTeX
@article{Wang2026,
  author = {Wang, Xiu-Heng and Yang, Jia-Yang and Lei, Zheng-Wen and Zheng, Xue-Ting and Xie, Hui-Yi and Huang, Hong and Tang, Hui-Fang and Zhao, Yue and Jiang, Zhi-Sheng and Hu, Heng-Jing},
  title = {SIRT3 Activation by SGLT2 Inhibitor Mitigates Endothelial-To-Mesenchymal Transition in Dahl Salt-Sensitive Rats Induced by High-Salt Diet},
  journal = {American Journal of Hypertension},
  year = {2026},
  volume = {39},
  number = {4},
  pages = {578--585},
  doi = {10.1093/ajh/hpaf209}
}
Kostenlos starten →